tetano
Editor, Senior Moderator
J Clin Microbiol. 2012 Nov 14. [Epub ahead of print]
Comparative evaluation of the Nanosphere Verigene RV+ Assay with the Simplexa Flu A/B & RSV Kit for the detection of influenza and respiratory syncytial viruses.
Alby K, Popowitch EB, Miller MB.
Source
Clinical Microbiology/Immunology Laboratories UNC Health Care, Chapel Hill, NC.
Abstract
Using retrospective (n=200) and prospective (n=150) nasopharyngeal specimens, we evaluated the Nanosphere Verigene RV+ and the Focus Diagnostics Simplexa Flu A/B & RSV tests. Overall, the RV+ demonstrated a sensitivity/specificity of 96.6%/100% for influenza A, 100%/99.7% for influenza B, and 100%/100% for RSV, while the Simplexa test sensitivity/specificity was 82.8%/99.7%, 76.2%/100% and 94.6%/100%, respectively.
PMID:
23152547
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/23152547
Comparative evaluation of the Nanosphere Verigene RV+ Assay with the Simplexa Flu A/B & RSV Kit for the detection of influenza and respiratory syncytial viruses.
Alby K, Popowitch EB, Miller MB.
Source
Clinical Microbiology/Immunology Laboratories UNC Health Care, Chapel Hill, NC.
Abstract
Using retrospective (n=200) and prospective (n=150) nasopharyngeal specimens, we evaluated the Nanosphere Verigene RV+ and the Focus Diagnostics Simplexa Flu A/B & RSV tests. Overall, the RV+ demonstrated a sensitivity/specificity of 96.6%/100% for influenza A, 100%/99.7% for influenza B, and 100%/100% for RSV, while the Simplexa test sensitivity/specificity was 82.8%/99.7%, 76.2%/100% and 94.6%/100%, respectively.
PMID:
23152547
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/23152547